BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Oraya Therapeutics 

8000 Jarvis Avenue

Newark  California  94560  U.S.A.
Phone: 510-456-3700 Fax: n/a


SEARCH JOBS


Industry
Biotechnology

Segment
Start Up





 Company News
Oraya Therapeutics Release: Initial Three-Year Data From INTREPID Study Of Non-invasive Therapy For Wet AMD Presented At American Academy of Ophthalmology Annual Meeting 11/18/2013 10:33:25 AM    More...
Oraya Therapeutics Release: Initial Three-Year Data From INTREPID Study Of Non-invasive Therapy For Wet AMD Presented At American Academy of Ophthalmology Annual Meeting 11/18/2013 6:37:46 AM    More...
Oraya Therapeutics And OnCore Manufacturing Complete Production Of Innovative Device For Wet Age-Related Macular Degeneration 11/12/2013 10:13:37 AM    More...
Oraya Therapeutics INTREPID Study Demonstrates Two-Year Safety and Effectiveness of Non-Invasive Therapy for Wet AMD 9/25/2013 9:42:50 AM    More...
Oraya Therapeutics' INTREPID Study Published in Ophthalmology, the Official Journal of the American Academy of Ophthalmology 4/18/2013 8:57:48 AM    More...
New Therapy for Wet AMD Introduced in Switzerland by Oraya Therapeutics and EyeRAD 4/4/2013 12:03:15 PM    More...
Oraya Therapeutics's Successful INTREPID Study Outcomes Presented at EURETINA 2012 Congress 9/21/2012 9:40:33 AM    More...
Oraya Therapeutics Achieves Successful INTREPID Study Outcomes with a Non-Invasive Radiation Therapy for Wet AMD 5/3/2012 10:34:01 AM    More...
Oraya Therapeutics Completes Enrollment in Pioneering Sham-Controlled Study of Radiation Therapy for Wet AMD 5/18/2011 10:20:13 AM    More...
Oraya Therapeutics Granted European CE Mark for the IRayTM Stereotactic Radiotherapy System 4/7/2010 1:14:05 PM    More...
12

//-->